中文 | English
Return
Total: 98 , 1/10
Show Home Prev Next End page: GO
Author:(Dazhi ZHANG)

1.Analysis and comparison in optimized treatment of chronic recurrent hepatitis C

Yan FANG ; Qiongfang ZHANG ; Dazhi ZHANG

Chongqing Medicine 2015;(23):3218-3220

2.Dynamic analysis of academic influence on liver diseases journals during 2003-2008

Hongmei ZHU ; Dazhi ZHANG ; Hong REN

Chinese Journal of Medical Education Research 2012;11(7):763-766

3.A study on the effects of PPARγ ligand rosiglitazone in the growth of MGC803 cells transplanted into subrenal-capsule of mice

Lihui ZHU ; Li ZHANG ; Dazhi ZHONG

Cancer Research and Clinic 2008;20(3):155-157

4.Research progress of the natural small molecular products synergistically with antifungal agents to inhibit drug-resistant fungi.

Shanlun TAN ; Dazhi ZHANG ; Yuanying JIANG

Acta Pharmaceutica Sinica 2014;49(8):1097-104

5.Effects of Enalapril and Irbesartan on the Expression of Related Plasma Molecule-marker

Dazhi WANG ; Zhiqiang WANG ; Shuyu ZHANG

China Pharmacy 2007;0(31):-

6.Study of virtual touch tissue quantification in noninvasive assessment of the effect of transjugular intrahepatic portosystemic stent shunt

Mingqiong ZHANG ; Haitao RAN ; Xiaoping YE ; Yefeng ZHU ; Dazhi ZHANG

Chinese Journal of Ultrasonography 2013;(5):402-405

9.Effects of femoral nerve block combined with celecoxib on postoperative analgesia in elderly patients with hip fracture

Xuebing LIU ; Ke SUN ; Dazhi ZHANG ; Qingguo YANG

Chinese Journal of Anesthesiology 2011;31(1):40-43

10.Logistic Analysis of the Infectious ODDS Risks of Anticancer Drugs in GI Cancer Patients with Chemotherapy Regiments

Dazhi WANG ; Juan WANG ; Shuyu ZHANG ; Xiaolu YANG ;

Chinese Journal of Pharmacoepidemiology 2006;0(01):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 98 , 1/10 Show Home Prev Next End page: GO